nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—REN—osteoporosis	0.461	0.782	CbGaD
Captopril—ACE—osteoporosis	0.128	0.218	CbGaD
Captopril—ALB—Estropipate—osteoporosis	0.049	0.33	CbGbCtD
Captopril—SLC22A6—Conjugated Estrogens—osteoporosis	0.0272	0.184	CbGbCtD
Captopril—ALB—Estradiol—osteoporosis	0.0204	0.137	CbGbCtD
Captopril—ABCB1—Ethinyl Estradiol—osteoporosis	0.0165	0.111	CbGbCtD
Captopril—REN—forelimb zeugopod—osteoporosis	0.015	0.354	CbGeAlD
Captopril—CYP2D6—Cholecalciferol—osteoporosis	0.0124	0.0839	CbGbCtD
Captopril—ABCB1—Conjugated Estrogens—osteoporosis	0.0121	0.0818	CbGbCtD
Captopril—ABCB1—Estradiol—osteoporosis	0.0106	0.0718	CbGbCtD
Captopril—MMP9—periosteum—osteoporosis	0.00764	0.18	CbGeAlD
Captopril—ACE—forelimb zeugopod—osteoporosis	0.00641	0.151	CbGeAlD
Captopril—F2—vertebral column—osteoporosis	0.00552	0.13	CbGeAlD
Captopril—LTA4H—uterus—osteoporosis	0.00169	0.0399	CbGeAlD
Captopril—LTA4H—bone marrow—osteoporosis	0.00144	0.0338	CbGeAlD
Captopril—Enalapril—ACE—osteoporosis	0.0012	1	CrCbGaD
Captopril—MMP2—uterus—osteoporosis	0.0012	0.0283	CbGeAlD
Captopril—MMP2—Estradiol—Estropipate—osteoporosis	0.00107	0.418	CbGdCrCtD
Captopril—MMP9—uterus—osteoporosis	0.00104	0.0246	CbGeAlD
Captopril—MMP9—bone marrow—osteoporosis	0.000887	0.0209	CbGeAlD
Captopril—MMP2—Estradiol—Conjugated Estrogens—osteoporosis	0.000811	0.316	CbGdCrCtD
Captopril—F2—bone marrow—osteoporosis	0.000773	0.0182	CbGeAlD
Captopril—MMP2—Estradiol—Ethinyl Estradiol—osteoporosis	0.000682	0.266	CbGdCrCtD
Captopril—ACE—bone marrow—osteoporosis	0.000473	0.0111	CbGeAlD
Captopril—ABCB1—uterus—osteoporosis	0.000196	0.00461	CbGeAlD
Captopril—ABCB1—bone marrow—osteoporosis	0.000166	0.00392	CbGeAlD
Captopril—Feeling abnormal—Ibandronate—osteoporosis	0.00015	0.00122	CcSEcCtD
Captopril—Nervousness—Conjugated Estrogens—osteoporosis	0.000149	0.00121	CcSEcCtD
Captopril—Gastrointestinal pain—Ibandronate—osteoporosis	0.000148	0.00121	CcSEcCtD
Captopril—Arthralgia—Pamidronate—osteoporosis	0.000148	0.00121	CcSEcCtD
Captopril—Myalgia—Pamidronate—osteoporosis	0.000148	0.00121	CcSEcCtD
Captopril—Ill-defined disorder—Zoledronate—osteoporosis	0.000148	0.0012	CcSEcCtD
Captopril—Body temperature increased—Alendronate—osteoporosis	0.000147	0.0012	CcSEcCtD
Captopril—Abdominal pain—Alendronate—osteoporosis	0.000147	0.0012	CcSEcCtD
Captopril—Shock—Risedronate—osteoporosis	0.000147	0.0012	CcSEcCtD
Captopril—Anaemia—Zoledronate—osteoporosis	0.000147	0.0012	CcSEcCtD
Captopril—Discomfort—Pamidronate—osteoporosis	0.000147	0.00119	CcSEcCtD
Captopril—Angioedema—Zoledronate—osteoporosis	0.000145	0.00118	CcSEcCtD
Captopril—Gastrointestinal pain—Calcitriol—osteoporosis	0.000145	0.00118	CcSEcCtD
Captopril—Abdominal pain—Raloxifene—osteoporosis	0.000145	0.00118	CcSEcCtD
Captopril—Body temperature increased—Raloxifene—osteoporosis	0.000145	0.00118	CcSEcCtD
Captopril—Vision blurred—Conjugated Estrogens—osteoporosis	0.000144	0.00117	CcSEcCtD
Captopril—Malaise—Zoledronate—osteoporosis	0.000144	0.00117	CcSEcCtD
Captopril—Body temperature increased—Ibandronate—osteoporosis	0.000143	0.00117	CcSEcCtD
Captopril—Abdominal pain—Ibandronate—osteoporosis	0.000143	0.00117	CcSEcCtD
Captopril—Confusional state—Pamidronate—osteoporosis	0.000143	0.00117	CcSEcCtD
Captopril—Syncope—Zoledronate—osteoporosis	0.000143	0.00116	CcSEcCtD
Captopril—Anaphylactic shock—Pamidronate—osteoporosis	0.000142	0.00116	CcSEcCtD
Captopril—Rhinitis—Estradiol—osteoporosis	0.000141	0.00115	CcSEcCtD
Captopril—Hepatitis—Estradiol—osteoporosis	0.000141	0.00114	CcSEcCtD
Captopril—Palpitations—Zoledronate—osteoporosis	0.000141	0.00114	CcSEcCtD
Captopril—Body temperature increased—Calcitriol—osteoporosis	0.00014	0.00114	CcSEcCtD
Captopril—Abdominal pain—Calcitriol—osteoporosis	0.00014	0.00114	CcSEcCtD
Captopril—Angioedema—Conjugated Estrogens—osteoporosis	0.00014	0.00114	CcSEcCtD
Captopril—Shock—Pamidronate—osteoporosis	0.00014	0.00114	CcSEcCtD
Captopril—Loss of consciousness—Zoledronate—osteoporosis	0.00014	0.00114	CcSEcCtD
Captopril—Pharyngitis—Estradiol—osteoporosis	0.00014	0.00114	CcSEcCtD
Captopril—Thrombocytopenia—Pamidronate—osteoporosis	0.000139	0.00113	CcSEcCtD
Captopril—Vomiting—Etidronic acid—osteoporosis	0.000139	0.00113	CcSEcCtD
Captopril—Cough—Zoledronate—osteoporosis	0.000139	0.00113	CcSEcCtD
Captopril—Tachycardia—Pamidronate—osteoporosis	0.000139	0.00113	CcSEcCtD
Captopril—Rash—Etidronic acid—osteoporosis	0.000138	0.00112	CcSEcCtD
Captopril—Dermatitis—Etidronic acid—osteoporosis	0.000138	0.00112	CcSEcCtD
Captopril—Syncope—Conjugated Estrogens—osteoporosis	0.000137	0.00112	CcSEcCtD
Captopril—Headache—Etidronic acid—osteoporosis	0.000137	0.00111	CcSEcCtD
Captopril—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000136	0.00111	CcSEcCtD
Captopril—Asthenia—Estropipate—osteoporosis	0.000136	0.0011	CcSEcCtD
Captopril—Anorexia—Pamidronate—osteoporosis	0.000136	0.0011	CcSEcCtD
Captopril—Chest pain—Zoledronate—osteoporosis	0.000135	0.0011	CcSEcCtD
Captopril—Arthralgia—Zoledronate—osteoporosis	0.000135	0.0011	CcSEcCtD
Captopril—Myalgia—Zoledronate—osteoporosis	0.000135	0.0011	CcSEcCtD
Captopril—Palpitations—Conjugated Estrogens—osteoporosis	0.000135	0.0011	CcSEcCtD
Captopril—Insomnia—Risedronate—osteoporosis	0.000135	0.0011	CcSEcCtD
Captopril—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000135	0.00109	CcSEcCtD
Captopril—Paraesthesia—Risedronate—osteoporosis	0.000134	0.00109	CcSEcCtD
Captopril—Pruritus—Estropipate—osteoporosis	0.000134	0.00109	CcSEcCtD
Captopril—Discomfort—Zoledronate—osteoporosis	0.000134	0.00109	CcSEcCtD
Captopril—Asthenia—Alendronate—osteoporosis	0.000134	0.00109	CcSEcCtD
Captopril—Cough—Conjugated Estrogens—osteoporosis	0.000134	0.00109	CcSEcCtD
Captopril—Dyspnoea—Risedronate—osteoporosis	0.000133	0.00108	CcSEcCtD
Captopril—Erythema multiforme—Estradiol—osteoporosis	0.000133	0.00108	CcSEcCtD
Captopril—Hypotension—Pamidronate—osteoporosis	0.000133	0.00108	CcSEcCtD
Captopril—Dry mouth—Zoledronate—osteoporosis	0.000133	0.00108	CcSEcCtD
Captopril—Fatigue—Ethinyl Estradiol—osteoporosis	0.000132	0.00107	CcSEcCtD
Captopril—Pruritus—Alendronate—osteoporosis	0.000132	0.00107	CcSEcCtD
Captopril—Dyspepsia—Risedronate—osteoporosis	0.000132	0.00107	CcSEcCtD
Captopril—Constipation—Ethinyl Estradiol—osteoporosis	0.000131	0.00107	CcSEcCtD
Captopril—Confusional state—Zoledronate—osteoporosis	0.000131	0.00106	CcSEcCtD
Captopril—Flushing—Estradiol—osteoporosis	0.000131	0.00106	CcSEcCtD
Captopril—Arthralgia—Conjugated Estrogens—osteoporosis	0.00013	0.00106	CcSEcCtD
Captopril—Chest pain—Conjugated Estrogens—osteoporosis	0.00013	0.00106	CcSEcCtD
Captopril—Myalgia—Conjugated Estrogens—osteoporosis	0.00013	0.00106	CcSEcCtD
Captopril—Asthenia—Ibandronate—osteoporosis	0.00013	0.00106	CcSEcCtD
Captopril—Nausea—Etidronic acid—osteoporosis	0.00013	0.00106	CcSEcCtD
Captopril—Anaphylactic shock—Zoledronate—osteoporosis	0.00013	0.00106	CcSEcCtD
Captopril—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00013	0.00105	CcSEcCtD
Captopril—Diarrhoea—Estropipate—osteoporosis	0.00013	0.00105	CcSEcCtD
Captopril—Fatigue—Risedronate—osteoporosis	0.000129	0.00105	CcSEcCtD
Captopril—Insomnia—Pamidronate—osteoporosis	0.000129	0.00105	CcSEcCtD
Captopril—Pruritus—Ibandronate—osteoporosis	0.000128	0.00104	CcSEcCtD
Captopril—Constipation—Risedronate—osteoporosis	0.000128	0.00104	CcSEcCtD
Captopril—Shock—Zoledronate—osteoporosis	0.000128	0.00104	CcSEcCtD
Captopril—Paraesthesia—Pamidronate—osteoporosis	0.000128	0.00104	CcSEcCtD
Captopril—Diarrhoea—Alendronate—osteoporosis	0.000128	0.00104	CcSEcCtD
Captopril—Asthenia—Calcitriol—osteoporosis	0.000127	0.00104	CcSEcCtD
Captopril—Thrombocytopenia—Zoledronate—osteoporosis	0.000127	0.00103	CcSEcCtD
Captopril—Dyspnoea—Pamidronate—osteoporosis	0.000127	0.00103	CcSEcCtD
Captopril—Tachycardia—Zoledronate—osteoporosis	0.000127	0.00103	CcSEcCtD
Captopril—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000126	0.00103	CcSEcCtD
Captopril—Somnolence—Pamidronate—osteoporosis	0.000126	0.00103	CcSEcCtD
Captopril—Pruritus—Calcitriol—osteoporosis	0.000126	0.00102	CcSEcCtD
Captopril—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000125	0.00102	CcSEcCtD
Captopril—Diarrhoea—Raloxifene—osteoporosis	0.000125	0.00102	CcSEcCtD
Captopril—Dyspepsia—Pamidronate—osteoporosis	0.000125	0.00102	CcSEcCtD
Captopril—Dizziness—Estropipate—osteoporosis	0.000125	0.00102	CcSEcCtD
Captopril—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000125	0.00102	CcSEcCtD
Captopril—Alopecia—Estradiol—osteoporosis	0.000124	0.00101	CcSEcCtD
Captopril—Diarrhoea—Ibandronate—osteoporosis	0.000124	0.00101	CcSEcCtD
Captopril—Anorexia—Zoledronate—osteoporosis	0.000124	0.00101	CcSEcCtD
Captopril—Decreased appetite—Pamidronate—osteoporosis	0.000124	0.001	CcSEcCtD
Captopril—Dizziness—Alendronate—osteoporosis	0.000123	0.001	CcSEcCtD
Captopril—Shock—Conjugated Estrogens—osteoporosis	0.000123	0.001	CcSEcCtD
Captopril—Fatigue—Pamidronate—osteoporosis	0.000123	0.000996	CcSEcCtD
Captopril—Gastrointestinal pain—Risedronate—osteoporosis	0.000122	0.000994	CcSEcCtD
Captopril—Tachycardia—Conjugated Estrogens—osteoporosis	0.000122	0.000992	CcSEcCtD
Captopril—Constipation—Pamidronate—osteoporosis	0.000122	0.000988	CcSEcCtD
Captopril—Diarrhoea—Calcitriol—osteoporosis	0.000122	0.000988	CcSEcCtD
Captopril—Hypotension—Zoledronate—osteoporosis	0.000121	0.000986	CcSEcCtD
Captopril—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000121	0.000986	CcSEcCtD
Captopril—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000121	0.000986	CcSEcCtD
Captopril—Dizziness—Raloxifene—osteoporosis	0.000121	0.000985	CcSEcCtD
Captopril—Tension—Estradiol—osteoporosis	0.00012	0.000978	CcSEcCtD
Captopril—Vomiting—Estropipate—osteoporosis	0.00012	0.000978	CcSEcCtD
Captopril—Dysgeusia—Estradiol—osteoporosis	0.00012	0.000976	CcSEcCtD
Captopril—Dizziness—Ibandronate—osteoporosis	0.00012	0.000975	CcSEcCtD
Captopril—Rash—Estropipate—osteoporosis	0.000119	0.00097	CcSEcCtD
Captopril—Dermatitis—Estropipate—osteoporosis	0.000119	0.000969	CcSEcCtD
Captopril—Anorexia—Conjugated Estrogens—osteoporosis	0.000119	0.000969	CcSEcCtD
Captopril—Nervousness—Estradiol—osteoporosis	0.000119	0.000968	CcSEcCtD
Captopril—Headache—Estropipate—osteoporosis	0.000119	0.000964	CcSEcCtD
Captopril—Vomiting—Alendronate—osteoporosis	0.000119	0.000963	CcSEcCtD
Captopril—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000118	0.000962	CcSEcCtD
Captopril—Abdominal pain—Risedronate—osteoporosis	0.000118	0.000961	CcSEcCtD
Captopril—Body temperature increased—Risedronate—osteoporosis	0.000118	0.000961	CcSEcCtD
Captopril—Rash—Alendronate—osteoporosis	0.000118	0.000955	CcSEcCtD
Captopril—Insomnia—Zoledronate—osteoporosis	0.000117	0.000955	CcSEcCtD
Captopril—Dermatitis—Alendronate—osteoporosis	0.000117	0.000954	CcSEcCtD
Captopril—Feeling abnormal—Pamidronate—osteoporosis	0.000117	0.000952	CcSEcCtD
Captopril—Hypotension—Conjugated Estrogens—osteoporosis	0.000117	0.00095	CcSEcCtD
Captopril—Headache—Alendronate—osteoporosis	0.000117	0.000949	CcSEcCtD
Captopril—Paraesthesia—Zoledronate—osteoporosis	0.000117	0.000948	CcSEcCtD
Captopril—Vomiting—Raloxifene—osteoporosis	0.000117	0.000947	CcSEcCtD
Captopril—Gastrointestinal pain—Pamidronate—osteoporosis	0.000116	0.000945	CcSEcCtD
Captopril—Dyspnoea—Zoledronate—osteoporosis	0.000116	0.000941	CcSEcCtD
Captopril—Rash—Raloxifene—osteoporosis	0.000116	0.000939	CcSEcCtD
Captopril—Dermatitis—Raloxifene—osteoporosis	0.000115	0.000939	CcSEcCtD
Captopril—Somnolence—Zoledronate—osteoporosis	0.000115	0.000938	CcSEcCtD
Captopril—Vomiting—Ibandronate—osteoporosis	0.000115	0.000938	CcSEcCtD
Captopril—Headache—Raloxifene—osteoporosis	0.000115	0.000933	CcSEcCtD
Captopril—Rash—Ibandronate—osteoporosis	0.000114	0.00093	CcSEcCtD
Captopril—Dermatitis—Ibandronate—osteoporosis	0.000114	0.000929	CcSEcCtD
Captopril—Dyspepsia—Zoledronate—osteoporosis	0.000114	0.000929	CcSEcCtD
Captopril—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000114	0.000926	CcSEcCtD
Captopril—Ill-defined disorder—Estradiol—osteoporosis	0.000114	0.000925	CcSEcCtD
Captopril—Headache—Ibandronate—osteoporosis	0.000114	0.000924	CcSEcCtD
Captopril—Insomnia—Conjugated Estrogens—osteoporosis	0.000113	0.000919	CcSEcCtD
Captopril—Vomiting—Calcitriol—osteoporosis	0.000113	0.000918	CcSEcCtD
Captopril—Decreased appetite—Zoledronate—osteoporosis	0.000113	0.000918	CcSEcCtD
Captopril—Nausea—Estropipate—osteoporosis	0.000112	0.000914	CcSEcCtD
Captopril—Body temperature increased—Pamidronate—osteoporosis	0.000112	0.000913	CcSEcCtD
Captopril—Abdominal pain—Pamidronate—osteoporosis	0.000112	0.000913	CcSEcCtD
Captopril—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000112	0.000913	CcSEcCtD
Captopril—Angioedema—Estradiol—osteoporosis	0.000112	0.000911	CcSEcCtD
Captopril—Rash—Calcitriol—osteoporosis	0.000112	0.00091	CcSEcCtD
Captopril—Fatigue—Zoledronate—osteoporosis	0.000112	0.00091	CcSEcCtD
Captopril—Dermatitis—Calcitriol—osteoporosis	0.000112	0.00091	CcSEcCtD
Captopril—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000111	0.000906	CcSEcCtD
Captopril—Headache—Calcitriol—osteoporosis	0.000111	0.000905	CcSEcCtD
Captopril—Somnolence—Conjugated Estrogens—osteoporosis	0.000111	0.000903	CcSEcCtD
Captopril—Constipation—Zoledronate—osteoporosis	0.000111	0.000903	CcSEcCtD
Captopril—Nausea—Alendronate—osteoporosis	0.000111	0.0009	CcSEcCtD
Captopril—Malaise—Estradiol—osteoporosis	0.000111	0.000899	CcSEcCtD
Captopril—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00011	0.000895	CcSEcCtD
Captopril—Asthenia—Ethinyl Estradiol—osteoporosis	0.00011	0.000894	CcSEcCtD
Captopril—Syncope—Estradiol—osteoporosis	0.00011	0.000894	CcSEcCtD
Captopril—Nausea—Raloxifene—osteoporosis	0.000109	0.000885	CcSEcCtD
Captopril—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000109	0.000883	CcSEcCtD
Captopril—Pruritus—Ethinyl Estradiol—osteoporosis	0.000109	0.000882	CcSEcCtD
Captopril—Palpitations—Estradiol—osteoporosis	0.000108	0.000881	CcSEcCtD
Captopril—Fatigue—Conjugated Estrogens—osteoporosis	0.000108	0.000876	CcSEcCtD
Captopril—Nausea—Ibandronate—osteoporosis	0.000108	0.000876	CcSEcCtD
Captopril—Loss of consciousness—Estradiol—osteoporosis	0.000108	0.000876	CcSEcCtD
Captopril—Asthenia—Risedronate—osteoporosis	0.000107	0.000872	CcSEcCtD
Captopril—Feeling abnormal—Zoledronate—osteoporosis	0.000107	0.00087	CcSEcCtD
Captopril—Cough—Estradiol—osteoporosis	0.000107	0.00087	CcSEcCtD
Captopril—Constipation—Conjugated Estrogens—osteoporosis	0.000107	0.000869	CcSEcCtD
Captopril—Gastrointestinal pain—Zoledronate—osteoporosis	0.000106	0.000863	CcSEcCtD
Captopril—Pruritus—Risedronate—osteoporosis	0.000106	0.00086	CcSEcCtD
Captopril—Nausea—Calcitriol—osteoporosis	0.000106	0.000858	CcSEcCtD
Captopril—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000105	0.000853	CcSEcCtD
Captopril—Chest pain—Estradiol—osteoporosis	0.000104	0.000848	CcSEcCtD
Captopril—Arthralgia—Estradiol—osteoporosis	0.000104	0.000848	CcSEcCtD
Captopril—Myalgia—Estradiol—osteoporosis	0.000104	0.000848	CcSEcCtD
Captopril—Discomfort—Estradiol—osteoporosis	0.000103	0.000838	CcSEcCtD
Captopril—Abdominal pain—Zoledronate—osteoporosis	0.000103	0.000834	CcSEcCtD
Captopril—Body temperature increased—Zoledronate—osteoporosis	0.000103	0.000834	CcSEcCtD
Captopril—Diarrhoea—Risedronate—osteoporosis	0.000102	0.000832	CcSEcCtD
Captopril—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000102	0.000831	CcSEcCtD
Captopril—Dry mouth—Estradiol—osteoporosis	0.000102	0.00083	CcSEcCtD
Captopril—Asthenia—Pamidronate—osteoporosis	0.000102	0.000829	CcSEcCtD
Captopril—Dizziness—Ethinyl Estradiol—osteoporosis	0.000101	0.000824	CcSEcCtD
Captopril—Confusional state—Estradiol—osteoporosis	0.000101	0.00082	CcSEcCtD
Captopril—Pruritus—Pamidronate—osteoporosis	0.000101	0.000818	CcSEcCtD
Captopril—Anaphylactic shock—Estradiol—osteoporosis	0.0001	0.000813	CcSEcCtD
Captopril—Dizziness—Risedronate—osteoporosis	9.89e-05	0.000804	CcSEcCtD
Captopril—Body temperature increased—Conjugated Estrogens—osteoporosis	9.89e-05	0.000803	CcSEcCtD
Captopril—Abdominal pain—Conjugated Estrogens—osteoporosis	9.89e-05	0.000803	CcSEcCtD
Captopril—Shock—Estradiol—osteoporosis	9.85e-05	0.0008	CcSEcCtD
Captopril—Tachycardia—Estradiol—osteoporosis	9.77e-05	0.000794	CcSEcCtD
Captopril—Vomiting—Ethinyl Estradiol—osteoporosis	9.75e-05	0.000793	CcSEcCtD
Captopril—Diarrhoea—Pamidronate—osteoporosis	9.73e-05	0.000791	CcSEcCtD
Captopril—Rash—Ethinyl Estradiol—osteoporosis	9.67e-05	0.000786	CcSEcCtD
Captopril—Dermatitis—Ethinyl Estradiol—osteoporosis	9.66e-05	0.000785	CcSEcCtD
Captopril—Headache—Ethinyl Estradiol—osteoporosis	9.61e-05	0.000781	CcSEcCtD
Captopril—Vomiting—Risedronate—osteoporosis	9.51e-05	0.000773	CcSEcCtD
Captopril—Rash—Risedronate—osteoporosis	9.43e-05	0.000766	CcSEcCtD
Captopril—Dermatitis—Risedronate—osteoporosis	9.42e-05	0.000766	CcSEcCtD
Captopril—Dizziness—Pamidronate—osteoporosis	9.4e-05	0.000764	CcSEcCtD
Captopril—Headache—Risedronate—osteoporosis	9.37e-05	0.000761	CcSEcCtD
Captopril—Asthenia—Zoledronate—osteoporosis	9.32e-05	0.000757	CcSEcCtD
Captopril—Pruritus—Zoledronate—osteoporosis	9.19e-05	0.000747	CcSEcCtD
Captopril—Musculoskeletal discomfort—Estradiol—osteoporosis	9.12e-05	0.000741	CcSEcCtD
Captopril—Nausea—Ethinyl Estradiol—osteoporosis	9.11e-05	0.000741	CcSEcCtD
Captopril—Insomnia—Estradiol—osteoporosis	9.05e-05	0.000736	CcSEcCtD
Captopril—Vomiting—Pamidronate—osteoporosis	9.04e-05	0.000735	CcSEcCtD
Captopril—Paraesthesia—Estradiol—osteoporosis	8.99e-05	0.00073	CcSEcCtD
Captopril—Asthenia—Conjugated Estrogens—osteoporosis	8.97e-05	0.000729	CcSEcCtD
Captopril—Rash—Pamidronate—osteoporosis	8.97e-05	0.000729	CcSEcCtD
Captopril—Dermatitis—Pamidronate—osteoporosis	8.96e-05	0.000728	CcSEcCtD
Captopril—Dyspnoea—Estradiol—osteoporosis	8.92e-05	0.000725	CcSEcCtD
Captopril—Headache—Pamidronate—osteoporosis	8.91e-05	0.000724	CcSEcCtD
Captopril—Somnolence—Estradiol—osteoporosis	8.9e-05	0.000723	CcSEcCtD
Captopril—Diarrhoea—Zoledronate—osteoporosis	8.89e-05	0.000722	CcSEcCtD
Captopril—Nausea—Risedronate—osteoporosis	8.88e-05	0.000722	CcSEcCtD
Captopril—Pruritus—Conjugated Estrogens—osteoporosis	8.85e-05	0.000719	CcSEcCtD
Captopril—Dyspepsia—Estradiol—osteoporosis	8.81e-05	0.000716	CcSEcCtD
Captopril—Decreased appetite—Estradiol—osteoporosis	8.7e-05	0.000707	CcSEcCtD
Captopril—Fatigue—Estradiol—osteoporosis	8.63e-05	0.000701	CcSEcCtD
Captopril—Dizziness—Zoledronate—osteoporosis	8.59e-05	0.000698	CcSEcCtD
Captopril—Constipation—Estradiol—osteoporosis	8.56e-05	0.000696	CcSEcCtD
Captopril—Diarrhoea—Conjugated Estrogens—osteoporosis	8.56e-05	0.000695	CcSEcCtD
Captopril—Nausea—Pamidronate—osteoporosis	8.45e-05	0.000686	CcSEcCtD
Captopril—Dizziness—Conjugated Estrogens—osteoporosis	8.27e-05	0.000672	CcSEcCtD
Captopril—Vomiting—Zoledronate—osteoporosis	8.26e-05	0.000671	CcSEcCtD
Captopril—Feeling abnormal—Estradiol—osteoporosis	8.25e-05	0.00067	CcSEcCtD
Captopril—Rash—Zoledronate—osteoporosis	8.19e-05	0.000665	CcSEcCtD
Captopril—Gastrointestinal pain—Estradiol—osteoporosis	8.18e-05	0.000665	CcSEcCtD
Captopril—Dermatitis—Zoledronate—osteoporosis	8.18e-05	0.000665	CcSEcCtD
Captopril—Headache—Zoledronate—osteoporosis	8.14e-05	0.000661	CcSEcCtD
Captopril—Vomiting—Conjugated Estrogens—osteoporosis	7.95e-05	0.000646	CcSEcCtD
Captopril—Body temperature increased—Estradiol—osteoporosis	7.91e-05	0.000643	CcSEcCtD
Captopril—Abdominal pain—Estradiol—osteoporosis	7.91e-05	0.000643	CcSEcCtD
Captopril—Rash—Conjugated Estrogens—osteoporosis	7.89e-05	0.000641	CcSEcCtD
Captopril—Dermatitis—Conjugated Estrogens—osteoporosis	7.88e-05	0.00064	CcSEcCtD
Captopril—Headache—Conjugated Estrogens—osteoporosis	7.83e-05	0.000637	CcSEcCtD
Captopril—Nausea—Zoledronate—osteoporosis	7.71e-05	0.000627	CcSEcCtD
Captopril—Nausea—Conjugated Estrogens—osteoporosis	7.43e-05	0.000604	CcSEcCtD
Captopril—Asthenia—Estradiol—osteoporosis	7.18e-05	0.000584	CcSEcCtD
Captopril—Pruritus—Estradiol—osteoporosis	7.08e-05	0.000575	CcSEcCtD
Captopril—Diarrhoea—Estradiol—osteoporosis	6.85e-05	0.000557	CcSEcCtD
Captopril—Dizziness—Estradiol—osteoporosis	6.62e-05	0.000538	CcSEcCtD
Captopril—Vomiting—Estradiol—osteoporosis	6.36e-05	0.000517	CcSEcCtD
Captopril—Rash—Estradiol—osteoporosis	6.31e-05	0.000513	CcSEcCtD
Captopril—Dermatitis—Estradiol—osteoporosis	6.31e-05	0.000512	CcSEcCtD
Captopril—Headache—Estradiol—osteoporosis	6.27e-05	0.00051	CcSEcCtD
Captopril—Nausea—Estradiol—osteoporosis	5.95e-05	0.000483	CcSEcCtD
Captopril—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	4.67e-05	0.000503	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	4.55e-05	0.00049	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.51e-05	0.000485	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	4.49e-05	0.000483	CbGpPWpGaD
Captopril—ALB—Hemostasis—CAP1—osteoporosis	4.48e-05	0.000482	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6R—osteoporosis	4.44e-05	0.000478	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	4.42e-05	0.000475	CbGpPWpGaD
Captopril—LTA4H—Metabolism—POMC—osteoporosis	4.4e-05	0.000474	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	4.38e-05	0.000471	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TGFB1—osteoporosis	4.34e-05	0.000467	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	4.27e-05	0.00046	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SOST—osteoporosis	4.23e-05	0.000455	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IGF1—osteoporosis	4.22e-05	0.000454	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	4.18e-05	0.00045	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—LEP—osteoporosis	4.09e-05	0.00044	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6R—osteoporosis	4.09e-05	0.000439	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL6—osteoporosis	4.08e-05	0.000439	CbGpPWpGaD
Captopril—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.08e-05	0.000439	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	4.07e-05	0.000438	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL6—osteoporosis	3.99e-05	0.000429	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MGLL—osteoporosis	3.94e-05	0.000424	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LRP5—osteoporosis	3.84e-05	0.000413	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CALCR—osteoporosis	3.83e-05	0.000412	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTH1R—osteoporosis	3.83e-05	0.000412	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—IGF1—osteoporosis	3.78e-05	0.000406	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PTH—osteoporosis	3.75e-05	0.000403	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	3.7e-05	0.000398	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—LEP—osteoporosis	3.68e-05	0.000396	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LRP6—osteoporosis	3.68e-05	0.000395	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CNR2—osteoporosis	3.65e-05	0.000393	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	3.6e-05	0.000387	CbGpPWpGaD
Captopril—ALB—Hemostasis—MGLL—osteoporosis	3.56e-05	0.000383	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IL6—osteoporosis	3.54e-05	0.000381	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—POMC—osteoporosis	3.52e-05	0.000378	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—LEP—osteoporosis	3.48e-05	0.000374	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PTH—osteoporosis	3.4e-05	0.000366	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL1B—osteoporosis	3.4e-05	0.000366	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—IGF1—osteoporosis	3.38e-05	0.000364	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ACE—osteoporosis	3.34e-05	0.000359	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.32e-05	0.000358	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.32e-05	0.000358	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CNR2—osteoporosis	3.32e-05	0.000357	CbGpPWpGaD
Captopril—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.31e-05	0.000356	CbGpPWpGaD
Captopril—ALB—Hemostasis—ANXA2—osteoporosis	3.25e-05	0.00035	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLEK—osteoporosis	3.25e-05	0.00035	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.24e-05	0.000349	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—POMC—osteoporosis	3.16e-05	0.00034	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	3.14e-05	0.000338	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—WNT1—osteoporosis	3.12e-05	0.000335	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PTHLH—osteoporosis	3.11e-05	0.000334	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TLN1—osteoporosis	3.1e-05	0.000334	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—IGF1—osteoporosis	3.04e-05	0.000327	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MGLL—osteoporosis	3.04e-05	0.000327	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	3.03e-05	0.000326	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LRP5—osteoporosis	2.97e-05	0.000319	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	2.95e-05	0.000317	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	2.93e-05	0.000315	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6R—osteoporosis	2.92e-05	0.000314	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	2.89e-05	0.00031	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB1—osteoporosis	2.84e-05	0.000306	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LRP6—osteoporosis	2.84e-05	0.000305	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PTHLH—osteoporosis	2.82e-05	0.000303	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.82e-05	0.000303	CbGpPWpGaD
Captopril—ALB—Hemostasis—TLN1—osteoporosis	2.81e-05	0.000302	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—osteoporosis	2.77e-05	0.000298	CbGpPWpGaD
Captopril—ALB—Hemostasis—VCL—osteoporosis	2.77e-05	0.000298	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.74e-05	0.000295	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CALCA—osteoporosis	2.73e-05	0.000294	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	2.7e-05	0.000291	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—P4HB—osteoporosis	2.68e-05	0.000288	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TGFB1—osteoporosis	2.63e-05	0.000283	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTH—osteoporosis	2.6e-05	0.00028	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.59e-05	0.000279	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL1B—osteoporosis	2.58e-05	0.000278	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RAP1A—osteoporosis	2.56e-05	0.000275	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CNR2—osteoporosis	2.54e-05	0.000273	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.53e-05	0.000272	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—POMC—osteoporosis	2.53e-05	0.000272	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NFATC1—osteoporosis	2.5e-05	0.000269	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CALCA—osteoporosis	2.48e-05	0.000267	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DKK1—osteoporosis	2.48e-05	0.000266	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.47e-05	0.000266	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—osteoporosis	2.47e-05	0.000265	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—osteoporosis	2.45e-05	0.000264	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	2.45e-05	0.000263	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TLN1—osteoporosis	2.4e-05	0.000258	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—WNT1—osteoporosis	2.39e-05	0.000257	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGA—osteoporosis	2.32e-05	0.00025	CbGpPWpGaD
Captopril—ALB—Hemostasis—RAP1A—osteoporosis	2.31e-05	0.000249	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB1—osteoporosis	2.27e-05	0.000244	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.2e-05	0.000237	CbGpPWpGaD
Captopril—F2—Hemostasis—IGF1—osteoporosis	2.18e-05	0.000234	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	2.16e-05	0.000232	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTHLH—osteoporosis	2.16e-05	0.000232	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—BMP2—osteoporosis	2.16e-05	0.000232	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGB—osteoporosis	2.11e-05	0.000227	CbGpPWpGaD
Captopril—ALB—Hemostasis—FGA—osteoporosis	2.1e-05	0.000226	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—LEP—osteoporosis	2.07e-05	0.000223	CbGpPWpGaD
Captopril—F2—Signaling Pathways—P4HB—osteoporosis	2.07e-05	0.000222	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PSMA5—osteoporosis	2.04e-05	0.000219	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PSMA2—osteoporosis	2.04e-05	0.000219	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.03e-05	0.000219	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTH—osteoporosis	2.01e-05	0.000216	CbGpPWpGaD
Captopril—ALB—Metabolism—FDPS—osteoporosis	2.01e-05	0.000216	CbGpPWpGaD
Captopril—ALB—Metabolism—PKM—osteoporosis	2.01e-05	0.000216	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—osteoporosis	2e-05	0.000216	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—osteoporosis	1.99e-05	0.000214	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—osteoporosis	1.98e-05	0.000213	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RAP1A—osteoporosis	1.98e-05	0.000213	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—osteoporosis	1.96e-05	0.000211	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CNR2—osteoporosis	1.96e-05	0.000211	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.95e-05	0.00021	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ADCY5—osteoporosis	1.94e-05	0.000209	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NFATC1—osteoporosis	1.93e-05	0.000207	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DKK1—osteoporosis	1.91e-05	0.000206	CbGpPWpGaD
Captopril—ALB—Hemostasis—FGB—osteoporosis	1.91e-05	0.000205	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.91e-05	0.000205	CbGpPWpGaD
Captopril—ALB—Metabolism—PGLS—osteoporosis	1.9e-05	0.000205	CbGpPWpGaD
Captopril—ALB—Metabolism—GPD2—osteoporosis	1.9e-05	0.000205	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CALCA—osteoporosis	1.9e-05	0.000204	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—osteoporosis	1.87e-05	0.000201	CbGpPWpGaD
Captopril—F2—Signaling Pathways—WNT1—osteoporosis	1.84e-05	0.000198	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—osteoporosis	1.82e-05	0.000196	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGA—osteoporosis	1.79e-05	0.000193	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—POMC—osteoporosis	1.78e-05	0.000192	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ADCY5—osteoporosis	1.77e-05	0.00019	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PKM—osteoporosis	1.76e-05	0.000189	CbGpPWpGaD
Captopril—ABCB1—Metabolism—FDPS—osteoporosis	1.76e-05	0.000189	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—POMC—osteoporosis	1.76e-05	0.000189	CbGpPWpGaD
Captopril—ALB—Metabolism—PNP—osteoporosis	1.74e-05	0.000187	CbGpPWpGaD
Captopril—ALB—Metabolism—ATIC—osteoporosis	1.74e-05	0.000187	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KL—osteoporosis	1.72e-05	0.000186	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—osteoporosis	1.72e-05	0.000185	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—IGF1—osteoporosis	1.71e-05	0.000184	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	1.68e-05	0.00018	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PGLS—osteoporosis	1.67e-05	0.000179	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPD2—osteoporosis	1.67e-05	0.000179	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTHLH—osteoporosis	1.67e-05	0.000179	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BMP2—osteoporosis	1.67e-05	0.000179	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—FDPS—osteoporosis	1.66e-05	0.000178	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PKM—osteoporosis	1.66e-05	0.000178	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.65e-05	0.000178	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGB—osteoporosis	1.63e-05	0.000175	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—osteoporosis	1.61e-05	0.000173	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—osteoporosis	1.58e-05	0.00017	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PSMA2—osteoporosis	1.57e-05	0.000169	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PSMA5—osteoporosis	1.57e-05	0.000169	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PGLS—osteoporosis	1.57e-05	0.000169	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPD2—osteoporosis	1.57e-05	0.000169	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ATIC—osteoporosis	1.53e-05	0.000164	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PNP—osteoporosis	1.53e-05	0.000164	CbGpPWpGaD
Captopril—ALB—Metabolism—CA2—osteoporosis	1.48e-05	0.000159	CbGpPWpGaD
Captopril—ALB—Metabolism—OXCT1—osteoporosis	1.48e-05	0.000159	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CALCA—osteoporosis	1.47e-05	0.000158	CbGpPWpGaD
Captopril—ALB—Metabolism—MGLL—osteoporosis	1.44e-05	0.000155	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ATIC—osteoporosis	1.44e-05	0.000155	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PNP—osteoporosis	1.44e-05	0.000155	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—POMC—osteoporosis	1.43e-05	0.000154	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.36e-05	0.000146	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADCY5—osteoporosis	1.35e-05	0.000145	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KL—osteoporosis	1.33e-05	0.000143	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SPP1—osteoporosis	1.31e-05	0.000141	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—osteoporosis	1.31e-05	0.00014	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—POMC—osteoporosis	1.3e-05	0.00014	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—osteoporosis	1.3e-05	0.00014	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CA2—osteoporosis	1.3e-05	0.00014	CbGpPWpGaD
Captopril—ABCB1—Metabolism—OXCT1—osteoporosis	1.3e-05	0.00014	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6R—osteoporosis	1.27e-05	0.000136	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MGLL—osteoporosis	1.26e-05	0.000136	CbGpPWpGaD
Captopril—ALB—Metabolism—IDH2—osteoporosis	1.23e-05	0.000132	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—OXCT1—osteoporosis	1.22e-05	0.000131	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CA2—osteoporosis	1.22e-05	0.000131	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MGLL—osteoporosis	1.19e-05	0.000128	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IRS2—osteoporosis	1.18e-05	0.000127	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LEP—osteoporosis	1.16e-05	0.000124	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP27A1—osteoporosis	1.15e-05	0.000124	CbGpPWpGaD
Captopril—ALB—Metabolism—ACP5—osteoporosis	1.12e-05	0.000121	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.11e-05	0.000119	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ESR1—osteoporosis	1.1e-05	0.000119	CbGpPWpGaD
Captopril—ABCB1—Metabolism—IDH2—osteoporosis	1.07e-05	0.000116	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.06e-05	0.000114	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADCY5—osteoporosis	1.04e-05	0.000112	CbGpPWpGaD
Captopril—ALB—Metabolism—TPI1—osteoporosis	1.04e-05	0.000112	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IRS1—osteoporosis	1.03e-05	0.000111	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—IDH2—osteoporosis	1.01e-05	0.000109	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP27A1—osteoporosis	1.01e-05	0.000109	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SPP1—osteoporosis	1.01e-05	0.000109	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1e-05	0.000108	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—POMC—osteoporosis	9.94e-06	0.000107	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.92e-06	0.000107	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.89e-06	0.000106	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ACP5—osteoporosis	9.83e-06	0.000106	CbGpPWpGaD
Captopril—ALB—Metabolism—P4HB—osteoporosis	9.81e-06	0.000106	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6R—osteoporosis	9.7e-06	0.000104	CbGpPWpGaD
Captopril—ALB—Metabolism—GAPDH—osteoporosis	9.63e-06	0.000104	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1—osteoporosis	9.56e-06	0.000103	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP27A1—osteoporosis	9.52e-06	0.000102	CbGpPWpGaD
Captopril—ALB—Metabolism—RAP1A—osteoporosis	9.38e-06	0.000101	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ACP5—osteoporosis	9.26e-06	9.97e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.26e-06	9.96e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	9.24e-06	9.94e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TPI1—osteoporosis	9.14e-06	9.83e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IRS2—osteoporosis	9.13e-06	9.82e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LEP—osteoporosis	8.93e-06	9.61e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF1—osteoporosis	8.64e-06	9.29e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TPI1—osteoporosis	8.61e-06	9.26e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—P4HB—osteoporosis	8.59e-06	9.24e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ESR1—osteoporosis	8.53e-06	9.17e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GAPDH—osteoporosis	8.43e-06	9.07e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—RAP1A—osteoporosis	8.22e-06	8.84e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.18e-06	8.8e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—P4HB—osteoporosis	8.1e-06	8.71e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IRS1—osteoporosis	7.97e-06	8.57e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GAPDH—osteoporosis	7.95e-06	8.55e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—RAP1A—osteoporosis	7.74e-06	8.33e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—POMC—osteoporosis	7.67e-06	8.25e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ENO1—osteoporosis	7.58e-06	8.15e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6R—osteoporosis	7.49e-06	8.05e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PSMA5—osteoporosis	7.47e-06	8.03e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PSMA2—osteoporosis	7.47e-06	8.03e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1—osteoporosis	7.38e-06	7.94e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ENO1—osteoporosis	6.64e-06	7.14e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PSMA5—osteoporosis	6.54e-06	7.04e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PSMA2—osteoporosis	6.54e-06	7.04e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ENO1—osteoporosis	6.26e-06	6.73e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PSMA2—osteoporosis	6.17e-06	6.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PSMA5—osteoporosis	6.17e-06	6.63e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP19A1—osteoporosis	6.06e-06	6.52e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—osteoporosis	5.75e-06	6.18e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—osteoporosis	5.73e-06	6.17e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—osteoporosis	5.64e-06	6.07e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP19A1—osteoporosis	5.31e-06	5.71e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—osteoporosis	5.18e-06	5.57e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP19A1—osteoporosis	5e-06	5.38e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ADCY5—osteoporosis	4.95e-06	5.33e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GPX1—osteoporosis	4.93e-06	5.31e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTHFR—osteoporosis	4.55e-06	4.9e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—osteoporosis	4.44e-06	4.77e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—osteoporosis	4.43e-06	4.76e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADCY5—osteoporosis	4.34e-06	4.67e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPX1—osteoporosis	4.32e-06	4.65e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—osteoporosis	4.32e-06	4.65e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADCY5—osteoporosis	4.09e-06	4.4e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPX1—osteoporosis	4.07e-06	4.38e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—osteoporosis	3.99e-06	4.29e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—osteoporosis	3.76e-06	4.04e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—POMC—osteoporosis	3.64e-06	3.92e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—osteoporosis	3.33e-06	3.59e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—POMC—osteoporosis	3.19e-06	3.43e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—POMC—osteoporosis	3.01e-06	3.23e-05	CbGpPWpGaD
